The Impact of Delay Between Biologic Prescription and Therapy Initiation on Clinical Outcomes in Inflammatory Bowel Disease Patients

被引：3
|
作者：
Agrawal, Manasi
Tepler, Adam
Hong, Simon
Advani, Rashmi
Lukin, Dana
机构：
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA
[2] Northwell Hlth, Lenox Hill Hosp, New York, NY USA
[3] Weill Cornell Med Ctr, New York, NY USA
来源：
GASTROENTEROLOGY | 2019年 / 157卷 / 01期
关键词：
D O I：
10.1053/j.gastro.2019.05.017
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E23 / E23
页数：1
相关论文
共 50 条
  • [41] Biologic therapy for inflammatory bowel disease comes of age
    Hanauer S.B.
    Current Gastroenterology Reports, 2007, 9 (6) : 485 - 488
  • [42] Biologic therapy for inflammatory bowel disease comes of age
    Stephen B. Hanauer
    Current Gastroenterology Reports, 2008, 10 (6)
  • [43] The Role of Early Biologic Therapy in Inflammatory Bowel Disease
    Berg, Dana Rachel
    Colombel, Jean-Frederic
    Ungaro, Ryan
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (12) : 1896 - 1905
  • [44] Leucocytapheresis for inflammatory bowel disease in the era of biologic therapy
    Hanai, Hiroyuki
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (07) : 596 - 600
  • [45] The Role of Biologic Therapy in Inflammatory Bowel Disease - Preface
    Lichtenstein, Gary R.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2006, 35 (04) : XIII - XIV
  • [46] Dual biologic therapy in pediatric Inflammatory Bowel Disease
    Abbas, R.
    Ibrahim, N.
    Elawad, M.
    Al-Mudahka, F.
    Abdelrhman, H.
    Akobeng, A. K.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 747 - 747
  • [47] Evolutionary biologic therapy for inflammatory bowel disease.
    Hanauer S.B.
    Current Gastroenterology Reports, 1999, 1 (6) : 467 - 469
  • [48] Impact of Angiotensin II Signaling Blockade on Clinical Outcomes in Patients with Inflammatory Bowel Disease
    Jacobs, Jeffrey D.
    Wagner, Thomas
    Gulotta, George
    Liao, Chuanhong
    Li, Yan Chun
    Bissonnette, Marc
    Pekow, Joel
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (07) : 1938 - 1944
  • [49] Impact of Angiotensin II Signaling Blockade on Clinical Outcomes in Patients with Inflammatory Bowel Disease
    Jeffrey D. Jacobs
    Thomas Wagner
    George Gulotta
    Chuanhong Liao
    Yan Chun Li
    Marc Bissonnette
    Joel Pekow
    Digestive Diseases and Sciences, 2019, 64 : 1938 - 1944
  • [50] Daily aspirin use does not impact clinical outcomes in patients with inflammatory bowel disease
    Patel, P.
    Gao, G.
    Gulotta, G.
    Rubin, D. T.
    Dalal, S.
    Cohen, R. D.
    Sakuraba, A.
    Pekow, J.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S293 - S293
12345